SIEMENS HEALTH ADR/050 (SHL1) - Net Assets
Based on the latest financial reports, SIEMENS HEALTH ADR/050 (SHL1) has net assets worth €18.48 Billion EUR (≈ $21.61 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€44.27 Billion ≈ $51.75 Billion USD) and total liabilities (€25.79 Billion ≈ $30.15 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore SHL1 cash flow metrics to assess how effectively this company generates cash.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €18.48 Billion |
| % of Total Assets | 41.75% |
| Annual Growth Rate | -4.12% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 4.65 |
SIEMENS HEALTH ADR/050 - Net Assets Trend (2022–2024)
This chart illustrates how SIEMENS HEALTH ADR/050's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of SIEMENS HEALTH ADR/050 for the complete picture of this company's asset base.
Annual Net Assets for SIEMENS HEALTH ADR/050 (2022–2024)
The table below shows the annual net assets of SIEMENS HEALTH ADR/050 from 2022 to 2024. For live valuation and market cap data, see SHL1 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | €18.25 Billion ≈ $21.33 Billion |
+0.63% |
| 2023-09-30 | €18.13 Billion ≈ $21.20 Billion |
-8.66% |
| 2022-09-30 | €19.85 Billion ≈ $23.21 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SIEMENS HEALTH ADR/050's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 140.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €2.15 Billion | 11.84% |
| Other Components | €16.05 Billion | 88.16% |
| Total Equity | €18.20 Billion | 100.00% |
SIEMENS HEALTH ADR/050 Competitors by Market Cap
The table below lists competitors of SIEMENS HEALTH ADR/050 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shengyi Technology Co Ltd
SHG:600183
|
$46.83 Billion |
|
Cameco Corp
TO:CCO
|
$46.84 Billion |
|
Diageo plc
MX:DEON
|
$46.84 Billion |
|
Targa Resources Inc
NYSE:TRGP
|
$46.85 Billion |
|
KBC Groep NV
BR:KBC
|
$46.27 Billion |
|
COMPASS GROUP
F:XGR
|
$46.25 Billion |
|
Nu Holdings Ltd.
F:M1Z
|
$46.24 Billion |
|
CoreWeave, Inc. Class A Common Stock
NASDAQ:CRWV
|
$46.19 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SIEMENS HEALTH ADR/050's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 18,081,000,000 to 18,199,000,000, a change of 118,000,000 (0.7%).
- Net income of 1,942,000,000 contributed positively to equity growth.
- Dividend payments of 1,063,000,000 reduced retained earnings.
- Other factors decreased equity by 761,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €1.94 Billion | +10.67% |
| Dividends Paid | €1.06 Billion | -5.84% |
| Other Changes | €-761.00 Million | -4.18% |
| Total Change | €- | 0.65% |
Book Value vs Market Value Analysis
This analysis compares SIEMENS HEALTH ADR/050's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.09x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-09-30 | €17.72 | €17.80 | x |
| 2023-09-30 | €16.20 | €17.80 | x |
| 2024-09-30 | €16.26 | €17.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SIEMENS HEALTH ADR/050 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.67%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.68%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 2.53x
- Recent ROE (10.67%) is above the historical average (9.76%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 10.27% | 9.39% | 0.44x | 2.47x | €54.40 Million |
| 2023 | 8.35% | 6.96% | 0.46x | 2.58x | €-299.10 Million |
| 2024 | 10.67% | 8.68% | 0.49x | 2.53x | €122.10 Million |
Industry Comparison
This section compares SIEMENS HEALTH ADR/050's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $37,411,546,005
- Average return on equity (ROE) among peers: -877.09%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SIEMENS HEALTH ADR/050 (SHL1) | €18.48 Billion | 10.27% | 1.40x | $46.68 Billion |
| LEPU MED.T.B. SP.GDR O.N. (07Z0) | $17.50 Billion | 7.19% | 0.43x | $146.67K |
| BIORETEC OY (0TN) | $9.74 Million | -47.38% | 0.18x | $16.10 Million |
| SYSMEX CORP.UNSP.ADR 1/2 (0YX0) | $349.05 Billion | 12.63% | 0.39x | $4.70 Billion |
| INMODE LTD IS -01 (154) | $703.81 Million | 25.76% | 0.12x | $711.77 Million |
| HeraMED Limited (1I4) | $76.93K | -8590.94% | 35.29x | $28.30 Million |
| Medtronic PLC (2M6) | $1.75 Billion | 30.35% | 0.38x | $83.04 Billion |
| Peijia Medical Limited (4WO) | $2.64 Billion | -15.46% | 0.26x | $391.36 Million |
| AVITA Medical Inc (51KB) | $20.86 Million | -118.03% | 0.23x | $172.49 Million |
| BRAINCOOL AB (5YL) | $111.74 Million | -54.84% | 0.19x | $21.56 Million |
| MICROPORT CARDIO.MEDTECH. (72X) | $2.33 Billion | -20.20% | 0.10x | $107.57 Million |
About SIEMENS HEALTH ADR/050
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound sys… Read more